首页> 美国卫生研究院文献>Canadian Family Physician >Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation.
【2h】

Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation.

机译:怀孕后停用抗抑郁药和苯二氮卓类药物。当心突然终止的风险。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

QUESTION: Two of my patients are planning to become pregnant. One is taking paroxetine and the other lorazepam. We have discussed what to do when they become pregnant and have decided they should stop taking these drugs as soon as pregnancy is confirmed. Is this the right decision? ANSWER: The decision to discontinue these drugs during pregnancy should be based on scientific evidence rather than "hearsay" that women should not take psychotropic medications during pregnancy. Recent epidemiologic studies have documented the relative safety of these drugs, so women should not feel compelled to stop taking them when they become pregnant. If, after receiving appropriate evidence-based information, a woman decides to stop taking the drugs, they should be gradually tapered off to avoid abrupt discontinuation syndrome.
机译:问题:我的两名患者计划怀孕。一种是服用帕罗西汀,另一种是劳拉西m。我们已经讨论了他们怀孕时该怎么办,并决定一旦确定怀孕就应该停止服用这些药物。这是正确的决定吗?答案:决定在怀孕期间停用这些药物的决定应基于科学证据,而不是“传闻”,即妇女在怀孕期间不应服用精神药物。最近的流行病学研究已证明这些药物的相对安全性,因此,妇女在怀孕时不应感到被迫停止服用。如果妇女在收到适当的循证信息后决定停止服用药物,则应逐渐减少服用这些药物的剂量,以避免突然停药综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号